You are viewing: Europe Cell Analysis Market analysis
Part of: Cell Analysis Market (Global)

The Europe Cell Analysis Market was valued at $313.46 Million in 2023 and projected to reach to $509.26 Million by 2028, representing a compound annual growth rate of 10.2%. Europe's cell analysis market is experiencing robust expansion, supported by advanced healthcare systems, substantial R&D investments, and a strong regulatory framework promoting innovation.

Europe Cell Analysis Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Cell Analysis Market Trends and Insights

  • Rest Of Asia Pacific is positioned as a high-growth region within the broader Asia Pacific cell analysis sector, driven by increasing healthcare investments and rising demand for advanced diagnostic technologies.
  • By 2028, Rest Of Asia Pacific is projected to reach $509.26 million, representing a compound annual growth rate of 10.2% over the forecast period. Rest Of Asia Pacific's cell analysis market benefits from expanding research infrastructure, growing adoption of flow cytometry and cell imaging systems, and increasing prevalence of chronic diseases requiring cellular diagnostics.
  • Rest Of Asia Pacific encompasses emerging economies with rising healthcare expenditures and improving laboratory capabilities.
  • The region's market growth is supported by both public and private sector investments in life sciences research and clinical diagnostics. Rest Of Asia Pacific continues to attract international market players seeking to establish regional presence and capitalize on untapped opportunities in cell analysis technologies.
  • Rest Of Asia Pacific's trajectory reflects broader trends in personalized medicine, immunotherapy development, and cellular research advancement across the Asia Pacific region..

Key Market Statistics

  • CAGR (2023-2028) 10.2% CAGR
  • Market Size, 2023 ~USD 313.46 Million
  • Forecast, 2028 ~USD 509.26 Million
  • Geography Europe

Europe Cell Analysis Market Overview

Market Leadership :

Europe commands a significant share of the global cell analysis market, with Germany leading at $3,183.38 million, establishing the region as a critical hub for advanced diagnostic and research technologies.

Strong Growth Trajectory :

The European cell analysis market is projected to grow at a 10.2% CAGR from 2023 to 2028, driven by robust healthcare infrastructure, regulatory support, and increasing adoption of cell-based therapies across the continent.

Diverse Market Composition :

Europe's market spans multiple developed economies including France ($2,084.29M), UK ($934.24M), Italy ($396.11M), and Spain ($309.15M), alongside emerging opportunities in Rest of Europe ($586.85M), creating a balanced and resilient market landscape.

Innovation and Investment :

European nations are investing heavily in cell analysis technologies for personalized medicine, immunotherapy development, and regenerative medicine applications, positioning the region as a global innovation leader.

Europe Cell Analysis Market Dynamics

  • The region's market value of $313.46 million in 2023 is projected to reach $509.26 million by 2028, reflecting the continent's commitment to cutting-edge diagnostic and therapeutic technologies. Key growth drivers include increasing prevalence of chronic diseases, rising demand for personalized medicine, and expanding applications in oncology and immunotherapy.
  • European countries are leveraging their scientific expertise and healthcare infrastructure to accelerate cell analysis adoption, positioning the region as a critical market for global manufacturers and research institutions..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Rest Of Asia Pacific cell analysis market valued at $313.46 million in 2023, expanding to $509.26 million by 2028 at 10.2% CAGR
      • Rest Of Asia Pacific demonstrates strong demand for flow cytometry and advanced cell imaging technologies driven by healthcare modernization
      • Rest Of Asia Pacific benefits from increasing research investments and growing adoption of cellular diagnostics in clinical and research settings
      • Rest Of Asia Pacific presents significant opportunities for market players through emerging economy expansion and rising laboratory infrastructure development

      Cell Analysis Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment SINGLE-CELL ANALYSIS (Process)
      Forecast Period 2023–2028
      Growth Rate CAGR of 10.9% from 2023 to 2028
      Largest Segment REAGENTS & CONSUMABLES (Product & Service)
      Market Size Base Year (Billions) ~USD 20.21 (2023)
      Revenue Forecast (Billions) ~USD 33.9 (2028)
      Segments Covered Product & Service, Technique, Process, End User

      Europe Cell Analysis Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product & Service

      • Accessories
      • Instruments
      • Reagents & Consumables
      • Services
      • Software

      By Technique

      • Cell Microarrays
      • Flow Cytometry
      • High-Content Screening
      • Microscopy
      • Other Techniques
      • Pcr
      • Spectrophotometry

      By Process

      • Cell Counting And Quality Control
      • Cell Identification
      • Cell Interaction
      • Cell Proliferation
      • Cell Signaling Pathways/ Signal Transduction
      • Cell Signaling Pathways/Signal Transduction
      • Cell Structure Study
      • Cell Viability
      • Single-Cell Analysis
      • Target Identification And Validation

      By End User

      • Academic And Research Institutes
      • Hospitals And Clinical Testing Laboratories
      • Other End Users
      • Pharmaceutica And Biotechnology Companies
      • Pharmaceutical & Biotechnology Companies
      • Pharmaceutical And Biotechnology Companies

      REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      ACADEMIC AND RESEARCH INSTITUTES75.9787.3295.1104.14114.87127.62142.8161.0811.1
      HOSPITALS AND CLINICAL TESTING LABORATORIES96.97112.38123.41136.26151.54169.75191.51217.7912
      OTHER END USERS108.02125.02137.11151.2167.94187.89211.71240.4711.9
      PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES149.04171.19186.32203.9224.76249.54279.04314.5311
      TOTAL430495.93541.95595.5659.11734.8825.06933.8611.5

      EUROPE: CELL ANALYSIS MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      ACADEMIC AND RESEARCH INSTITUTES835.92962.511050.121151.991272.951416.781588.191794.6211.3
      HOSPITALS AND CLINICAL TESTING LABORATORIES1067.391235.11354.161492.851657.721854.122088.682371.7911.9
      OTHER END USERS1189.141374.411505.191657.461838.452053.962311.232621.5911.7
      PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES1647.661894.232063.42260.012493.372770.73100.983498.4611.1
      TOTAL4740.115466.255972.876562.317262.498095.579089.0710286.4611.5

      Target Audience

      • Medical Device Manufacturers : Need detailed European market data to guide product development, regulatory compliance strategies, and market entry decisions across multiple European countries with varying healthcare standards.
      • Pharmaceutical Companies : Require insights into cell analysis adoption rates and therapeutic applications across Europe to support drug development pipelines, clinical trial planning, and commercialization strategies.
      • Healthcare Investors : Seek comprehensive market intelligence on European cell analysis growth opportunities, regional market valuations, and investment potential to identify high-return opportunities in the sector.
      • Research Institutions : Need market trend data and regional growth forecasts to secure funding, justify research initiatives, and align scientific programs with commercial market demands across European markets.
      • Healthcare Consultants : Require detailed regional market analysis to advise clients on market positioning, competitive strategies, and growth opportunities specific to the European cell analysis landscape.

      Key Companies in the Europe Cell Analysis Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing & packaging),Pharmaceutical development services (formulation & clinical supply),Drug substance services (API & biologics),
      ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
      BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry and diagnostics),BSI Nano (X-ray, AFM, microscopy, nano-metrology),
      WAFERGEN BIO-SYSTEMSUnited StatesPrivate CompanySmartChip Real-Time PCR and Target Enrichment Systems,SmartChip Single-Cell Isolation System,Apollo 324 Library Preparation System and Reagents,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      DANAHERUnited StatesPublic CompanyBiotechnology (bioprocessing and single-use solutions),Life Sciences (instruments, genomics, and analytical systems),Diagnostics (clinical instruments and consumables),
      GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & Services,Defense & Propulsion Technologies,Additive, Components & Other Systems,
      MERCK KGAAGermanyPublic CompanyLife Science (reagents, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, equipment),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research and Bioprocess,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy systems),Services, software, and other,
      OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Urology (visualization, stone management, BPH, bladder cancer),Respiratory (bronchoscopy, lung cancer, COPD),

      PATHEON INC

      Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and biotechnology services sector.

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees providing research reagents and tools for the life sciences industry.

      BRUKER CORPORATION

      Bruker Corporation is a publicly traded U.S. company founded in 1960 with 11,085 employees manufacturing scientific instruments and analytical solutions.

      WAFERGEN BIO-SYSTEMS

      WaferGen Bio-Systems is a U.S. private company founded in 2002 with 56 employees developing microfluidic and genomic analysis technologies.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a publicly traded U.S. company founded in 1956 with 125,000 employees serving the life sciences, analytical, and diagnostics markets.

      DANAHER

      Danaher is a publicly traded U.S. company founded in 1969 with 59,000 employees operating across diversified industrial and life sciences sectors.

      GENERAL ELECTRIC

      General Electric is a publicly traded U.S. company founded in 1892 with 57,000 employees operating across industrial, power, and healthcare sectors.

      MERCK KGAA

      Merck KGaA is a publicly traded German company founded in 1668 with 59,077 employees engaged in pharmaceuticals, life sciences, and performance materials.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a publicly traded U.S. company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a publicly traded U.S. company founded in 1952 with 7,450 employees manufacturing clinical diagnostics and life science research products.

      STANDARD BIOTOOLS

      Standard Biotools is a publicly traded U.S. company founded in 1999 with 387 employees developing microfluidic and genomic analysis platforms.

      OLYMPUS CORPORATION

      Olympus Corporation is a publicly traded Japanese company founded in 1919 with 28,138 employees manufacturing optical and digital precision instruments.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      Global
      ~USD 367.71 Million · 10.4% wtd CAGR ·
      North America
      ~USD 9213.43 Million · 11.7% wtd CAGR ·
      Asia Pacific
      ~USD 1621.83 Million · 11.4% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 3183.38 Million
      FranceUSD 2084.29 Million
      UKUSD 934.24 Million
      ItalyUSD 396.11 Million
      SpainUSD 309.15 Million
      Rest Of EuropeUSD 586.85 Million

      Country market size visualization

      Germany
      USD 3183.38 Million
      France
      USD 2084.29 Million
      UK
      USD 934.24 Million
      Italy
      USD 396.11 Million
      Spain
      USD 309.15 Million
      Rest Of Europe
      USD 586.85 Million

      Reasons to Buy this Report

      • Regional Market Segmentation : Gain detailed insights into Europe's cell analysis market broken down by major economies including Germany, France, UK, Italy, and Spain, enabling targeted market entry and expansion strategies.
      • Growth Forecasting : Access comprehensive projections through 2028 with a 10.2% CAGR, allowing stakeholders to plan investments, product launches, and resource allocation with confidence in market trajectory.
      • Competitive Intelligence : Understand the European competitive landscape, regulatory environment, and market dynamics specific to the region to identify opportunities and benchmark against regional leaders.
      • Investment Decision Support : Leverage market sizing data and growth forecasts to support investment decisions, partnership evaluations, and M&A strategies within Europe's high-growth cell analysis sector.
      • Strategic Planning : Develop evidence-based strategies for market penetration, product positioning, and resource optimization tailored to Europe's diverse healthcare systems and regulatory requirements.

      Frequently asked questions

      What is the current market size of cell analysis in Rest Of Asia Pacific?

      Rest Of Asia Pacific's cell analysis market was valued at $313.46 million in 2023 and is projected to grow to $509.26 million by 2028.

      What is the expected growth rate for Rest Of Asia Pacific cell analysis market?

      Rest Of Asia Pacific cell analysis market is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2028.

      What are the primary drivers of growth in Rest Of Asia Pacific cell analysis market?

      Rest Of Asia Pacific growth is driven by expanding healthcare infrastructure, increasing research investments, rising chronic disease prevalence, and growing adoption of advanced diagnostic technologies.

      Which technologies are most in demand in Rest Of Asia Pacific cell analysis market?

      Rest Of Asia Pacific shows strong demand for flow cytometry systems, cell imaging platforms, and advanced cellular diagnostic solutions used in research and clinical applications.

      What opportunities exist for market players in Rest Of Asia Pacific?

      Rest Of Asia Pacific offers opportunities through emerging market expansion, laboratory infrastructure development, partnerships with research institutions, and localized product offerings for regional healthcare needs.

      RESEARCH METHODOLOGY

      This study involved four major activities in estimating the current size of the cell analysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), Society for Laboratory Automation and Screening (SLAS), Centers for Medicare & Medicaid Services (CMS), National Cancer Institute (NCI), European Commission (EC), American Society for Cell Biology (ASCB), European Society for Toxicology In Vitro (ESTIV), European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan Society for Cell Biology (JSCB), Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Indian Society of Cell Biology (ISCB), Food and Drug Administration (FDA), Society of Biomolecular Imaging and Informatics (SBI2), Annual Reports, SEC Filings, Investor Presentations, Press Releases, Conferences, Journals, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Cell Analysis Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the cell analysis business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Cell Analysis Market Size, and Share

      Data Triangulation

      After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Cell analysis is a technique used to study groups of cells and individual cells based on multiple parameters. It is used to measure cell properties such as size, shape, presence of specific proteins, proliferation, growth, morphology, porosity, and complexity.

      Cell analysis products are used in various processes, which include cell identification, cell viability, cell proliferation, cell structure study, cell signaling pathway/signal transduction, cell counting & quality control, target identification & validation, cell interaction, and single-cell analysis. These processes are carried out by various end users such as hospitals & clinical testing laboratories, academic and research institutes, pharmaceutical & biotechnology companies, and other end users (CROs, cell culture collection repositories, food & beverage manufacturers, environmental monitoring organizations, forensic laboratories, and blood banks).

      Key Stakeholders

      • Pharmaceutical and biopharmaceutical companies
      • Manufacturers of cell analysis equipment
      • Contract research organizations (CROs)
      • Life science research institutes
      • Venture capitalists
      • Research & consulting firms

      Report Objectives

      • To define, describe, and forecast the global cell analysis market based on the product & service, technique, process, end user and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the cell analysis market.

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Company Information

      • An additional five company profiles

      Get the Full Cell Analysis Market Report

      Full forecast, segment splits, and company analysis for all Cell Analysis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status